TP53 and cancer: While the patients with mutant TP53 and high BCAR1 expression have shorter overall survival than the patients with low BCAR1 expression, we are unclear how much the mutant TP53−BCAR1 complex-mediated cancer cell invasion affects the reduction in overall survival.